Skip to main content
Premium Trial:

Request an Annual Quote

Laurence Reid, Gregory Verdine

Warp Drive Bio, which is using genomic technology for discovering therapeutics derived from natural products, appointed Laurence Reid its CEO. He succeeds Co-founder Gregory Verdine, who will serve as president and chief scientific officer, a board member, and chairman of Warp Drive's scientific advisory board. 

Reid most recently was chief business officer at Alnylam Pharmaceuticals. He is also an entrepreneur-in-residence at Third Rock Ventures. Prior to Alynylam, he was CBO at Ensemble Therapeutics and spent 10 years at Millennium Pharmaceuticals.